U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
ý |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE TRANSITION PERIOD FROM TO
Commission file number 000-33357
BRUKER AXS INC.
(Exact name of registrant as specified in its charter)
| Delaware (State or other jurisdiction of incorporation or organization) |
39-1908020 (IRS Employer Identification Number) |
5465 East Cheryl Parkway
Madison, WI 53711
(Address of principal executive offices)
(608) 276-3000
(Registrant's telephone number, including area code)
Check whether the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
(1) Yes ý No o
As of August 1, 2002 there were 56,180,338 shares of the Registrant's common stock outstanding.
| |
|
PAGE NUMBER |
||
|---|---|---|---|---|
| PART I | FINANCIAL INFORMATION | |||
ITEM 1: |
Financial Statements |
|||
| Condensed Consolidated Balance Sheets as of June 30, 2002 and December 31, 2001 | 3 | |||
| Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2002 and 2001 | 4 | |||
| Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2002 and 2001 | 5 | |||
| Notes to Condensed Consolidated Financial Statements | 6 | |||
ITEM 2: |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
14 |
||
ITEM 3: |
Quantitative and Qualitative Disclosures about Market Risk |
19 |
||
PART II |
OTHER INFORMATION |
|||
ITEM 1: |
Legal Proceedings |
22 |
||
ITEM 2: |
Changes in Securities and Use of Proceeds |
22 |
||
ITEM 3: |
Defaults Upon Senior Securities |
22 |
||
ITEM 4: |
Submission of Matters to a Vote of Security Holders |
22 |
||
ITEM 5: |
Other Information |
23 |
||
ITEM 6: |
Exhibits and Reports on Form 8-K |
23 |
||
SIGNATURES |
24 |
PART I. FINANCIAL INFORMATION
ITEM 1. Financial Statements
Bruker AXS Inc.
Condensed Consolidated Balance Sheets
| |
June 30, 2002 |
December 31, 2001 |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| |
(Unaudited) |
||||||||
| ASSETS | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | $ | 50,672,561 | $ | 48,787,026 | |||||
| Accounts receivable, net | 21,198,530 | 17,206,783 | |||||||
| Inventories | 34,532,499 | 26,768,962 | |||||||
| Prepaid expenses | 1,677,448 | 809,303 | |||||||
| Other assets | 1,391,016 | 951,625 | |||||||
| Deferred income taxes | 1,036,796 | 886,365 | |||||||
| Total current assets | 110,508,850 | 95,410,064 | |||||||
| Property and equipment, net | 18,300,233 | 8,150,910 | |||||||
| Restricted cash | 121,169 | 108,074 | |||||||
| Other | 334,865 | 1,053,620 | |||||||
| Intangible assetstrademarks and tradenames, net | 250,250 | 250,250 | |||||||
| Goodwill, net | 4,077,111 | 3,099,314 | |||||||
| Investments in other companies | 2,000,000 | 2,000,000 | |||||||
| Deferred income taxes | 2,186,511 | 2,018,314 | |||||||
| Total assets | $ | 137,778,989 | $ | 112,090,546 | |||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||
| Current liabilities: | |||||||||
| Short-term borrowings | $ | 1,956,765 | $ | 241,957 | |||||
| Current portion of long-term debt | 573,549 | | |||||||
| Related party debtcurrent | 253,036 | 229,180 | |||||||
| Accounts payable | 9,095,646 | 7,415,956 | |||||||
| Other current liabilities | 24,940,213 | 20,995,538 | |||||||
| Total current liabilities | 36,819,209 | 28,882,631 | |||||||
| Long-term debt | 9,055,037 | 2,200,000 | |||||||
| Accrued pension | 4,250,594 | 3,437,058 | |||||||
| Minority interest in consolidated subsidiary | 19,599 | | |||||||
| Shareholders' equity: | |||||||||
| Preferred stock, $.01 par value, 5,000,000 authorized, 0 shares issued and outstanding at June 30, 2002 and December 31, 2001 | | | |||||||
| Common stock, $.01 par value, 100,000,000 shares authorized, 56,180,338 and 54,830,338 shares issued and outstanding at June 30, 2002 and December 31, 2001, respectively | 561,804 | 548,304 | |||||||
| Additional paid-in capital | 87,118,989 | 79,135,021 | |||||||
| Accumulated deficit | (656,371 | ) | (1,574,502 | ) | |||||
| Accumulated other comprehensive income (loss) | 610,128 | (537,966 | ) | ||||||
| Total shareholders' equity | 87,634,550 | 77,570,857 | |||||||
| Total liabilities and shareholders' equity | $ | 137,778,989 | $ | 112,090,546 | |||||
The accompanying notes are an integral part of these financial statements.
3
Bruker AXS Inc.
Condensed Consolidated Statements of Operations
| |
Three Months Ended June 30, |
Six Months Ended June 30, |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
2002 |
2001 |
||||||||||
| |
(Unaudited) |
(Unaudited) |
||||||||||||
| Net sales | $ | 24,034,862 | $ | 20,208,053 | $ | 47,830,423 | $ | 39,053,537 | ||||||
Cost of sales |
14,659,919 |
12,449,269 |
29,337,536 |
24,162,383 |
||||||||||
Gross profit |
9,374,943 |
7,758,784 |
18,492,887 |
14,891,154 |
||||||||||
Operating expenses: |
||||||||||||||
| Research and development | 2,801,804 | 1,913,458 | 4,915,003 | 3,582,544 | ||||||||||
| In-process research and development | | 3,590,000 | | 3,590,000 | ||||||||||
| General and administrative | 2,013,585 | 1,293,824 | 3,611,698 | 2,262,758 | ||||||||||
| Marketing and selling | 5,058,168 | 4,251,301 | 9,726,321 | 7,967,235 | ||||||||||
| Total operating expenses | 9,873,557 | 11,048,583 | 18,253,022 | 17,402,537 | ||||||||||
Operating (loss) income |
(498,614 |
) |
(3,289,799 |
) |
239,865 |
(2,511,383 |
) |
|||||||
Other expense (income): |
||||||||||||||
| Interest income | (181,060 | ) | (126,089 | ) | (414,341 | ) | (286,729 | ) | ||||||
| Interest expensethird party | 61,175 | 106,736 | 121,696 | 160,188 | ||||||||||
| Interest expenserelated party | 1,056 | 79,794 | 2,047 | 153,565 | ||||||||||
| Other (income) expense | (1,391,318 | ) | (245,321 | ) | (984,598 | ) | 20,541 | |||||||
Income (loss) before income taxes and minority interest in subsidiary loss |
1,011,533 |
(3,104,919 |
) |
1,515,061 |
(2,558,948 |
) |
||||||||
Income tax expense (benefit) |
403,597 |
(1,267,929 |
) |
598,438 |
(986,397 |
) |
||||||||
| Income (loss) before minority interest in subsidiary loss | 607,936 | (1,836,990 | ) | 916,623 | (1,572,551 | ) | ||||||||
Minority interest in subsidiary loss |
648 |
|
1,508 |
|
||||||||||
Net income (loss) |
608,584 |
(1,836,990 |
) |
918,131 |
(1,572,551 |
) |
||||||||
Preferred stock dividend |
|
(369,862 |
) |
|
|
|||||||||
| Preferred stock accretion | | 166,881 | | 166,881 | ||||||||||
Net income (loss) available to common shareholders |
$ |
608,584 |
$ |
(1,634,009 |
) |
$ |
918,131 |
$ |
(1,739,432 |
) |
||||
Earnings (loss) per share: |
||||||||||||||
| Basic | $ | 0.01 | $ | (0.04 | ) | $ | 0.02 | $ | (0.04 | ) | ||||
| Diluted | $ | 0.01 | $ | (0.04 | ) | $ | 0.02 | $ | (0.04 | ) | ||||
The accompanying notes are an integral part of these financial statements.
4
Bruker AXS Inc.
Condensed Consolidated Statements of Cash Flows
| |
Six Months Ended June 30, |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
|||||||
| |
(Unaudited) |
||||||||
| Cash flows from operating activities: | |||||||||
| Net income (loss) | $ | 918,131 | $ | (1,572,551 | ) | ||||
| Adjustments to reconcile net income (loss) to cash flows used in operating activities: | |||||||||
| Depreciation and amortization | 1,506,294 | 1,380,541 | |||||||
| Deferred income taxes | (392,930 | ) | (1,554,933 | ) | |||||
| Provision for doubtful accounts | 220,533 | (52,410 | ) | ||||||
| Stock compensation | (138,612 | ) | 89,565 | ||||||
| Write-off of acquired in-process research and development | | 3,590,000 | |||||||
| Minority interest in consolidated subsidiary | (1,508 | ) | | ||||||
| Changes in operating assets and liabilities: | |||||||||
| Accounts receivable | (2,522,615 | ) | (3,115,018 | ) | |||||
| Inventories | (3,488,022 | ) | (2,417,536 | ) | |||||
| Other assets and prepaid expenses | (576,820 | ) | (299,359 | ) | |||||
| Accounts payable | 922,143 | 2,243,230 | |||||||
| Accrued pension | 404,494 | 355,022 | |||||||
| Other current liabilities | (900,749 | ) | 133,917 | ||||||
| Net cash used in operating activities | (4,049,661 | ) | (1,219,532 | ) | |||||
| Cash flows from investing activities: | |||||||||
| Purchase of property and equipment | (9,838,183 | ) | (1,001,492 | ) | |||||
| Cash contribution from minority shareholders | 21,107 | | |||||||
| Acquisition of MAC Science Ltd. | (274,101 | ) | | ||||||
| Acquisition of Nonius Group, net of cash acquired | | (6,235,547 | ) | ||||||
| Investment in other companies | | (500,000 | ) | ||||||
| Net cash used in investing activities | (10,091,177 | ) | (7,737,039 | ) | |||||
| Cash flows from financing activities: | |||||||||
| Proceeds from/(repayment of) line of credit | 1,554,468 | (5,307,125 | ) | ||||||
| Repayment of related party debt | | (1,043,584 | ) | ||||||
| Issuance of long-term debt | 6,882,507 | | |||||||
| Proceeds from issuance of common stock, net of issuance costs | 8,136,081 | | |||||||
| Proceeds from issuance of preferred stock, net of issuance costs | | 22,273,136 | |||||||
| Net cash provided by financing activities | 16,573,056 | 15,922,427 | |||||||
| Effect of exchange rate changes on cash | (546,683 | ) | (167,596 | ) | |||||
| Net increase in cash and cash equivalents | 1,885,535 | 6,798,260 | |||||||
| Cash and cash equivalents at beginning of period | 48,787,026 | 2,460,457 | |||||||
| Cash and cash equivalents at end of period | $ | 50,672,561 | $ | 9,258,717 | |||||
The accompanying notes are an integral part of these financial statements.
5
Bruker AXS Inc.
Notes to Condensed Consolidated Financial Statements
1. Description of Business and Basis of Presentation
Bruker AXS Inc. (the "Company") designs, manufactures, distributes and services systems and provides complete solutions in X-ray instrumentation used in non-destructive molecular and elemental analysis in academic, research and industrial applications.
The financial statements represent the consolidated accounts of Bruker AXS Inc. and its wholly- and majority-owned subsidiaries. All significant intercompany transactions and balances have been eliminated.
The condensed consolidated financial statements as of June 30, 2002 and for the three and six months ended June 30, 2002 and 2001 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2002 are not necessarily indicative of the results that may be expected for the year ending December 31, 2002. The balance sheet data as of December 31, 2001 has been derived from the audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
Although management believes that the disclosures are adequate to make the information presented not misleading, it is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2001, as filed with the Securities and Exchange Commission.
2. Summary of Significant Accounting Policies
Use of estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Minority interest in consolidated subsidiary
Minority interest in consolidated subsidiary represents the minority common shareholders' proportionate share of the equity of Incoatec GmbH, a German entity. Incoatec GmbH has been a consolidated subsidiary since February 2002 when the Company contributed $21,968 of cash to this entity. The Company also guarantees approximately $165,000 of Incoatec GmbH's debt. As of June 30, 2002, the Company owned 51% of Incoatec GmbH.
Software development costs
Certain direct development costs associated with internal-use software are capitalized, including external direct costs of material and services and payroll costs for employees devoting time to the software projects. These costs are included within property and equipment and are amortized on a
6
straight-line basis over a three- to five- year period beginning when the asset is substantially ready for use. Costs incurred during the preliminary project stage, as well as maintenance and training costs, are expensed when incurred.
Accounting pronouncements
In June 2001, the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ("SFAS") No. 143, "Accounting for Asset Retirement Obligations." SFAS No. 143 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred. When the liability is initially recorded, the entity capitalizes a cost by increasing the carrying amount of the related long-lived asset. Over time, the liability is accreted to its present value each period, and the capitalized cost is depreciated over the useful life of the related asset. Upon settlement of the liability, an entity either settles the obligation for its recorded amount or incurs a gain or loss upon settlement. The standard is effective for fiscal years beginning after June 15, 2002. The Company believes SFAS No. 143 will not have a material effect on the results of operations or financial position.
In August 2001, the FASB issued SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." SFAS No. 144 addresses financial accounting and reporting for the impairment or disposal of long-lived assets. The accounting model for long-lived assets to be disposed of by sale applies to all long-lived assets, including discontinued operations. SFAS No. 144 requires that those long-lived assets be measured at the lower of carrying amount or fair value less cost to sell, whether reported in continuing operations or in discontinued operations. Therefore, discontinued operations will no longer be measured at net realizable value or include amounts for operating losses that have not yet occurred. SFAS No. 144 also broadens the reporting of discontinued operations to include all components of an entity with operations that can be distinguished from the rest of the entity and that will be eliminated from the ongoing operations of the entity in a disposal transaction. The provisions of this statement are effective for financial statements issued for fiscal years beginning after December 15, 2001, and interim periods within those fiscal years, with early application encouraged. The Company adopted this statement on January 1, 2002. SFAS No. 144 did not have a material effect on the results of operations or financial position.
In April 2002, the FASB issued SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB No. 13, and Technical Corrections." This statement requires that gains or losses from extinguishments of debt should be classified as extraordinary items only if they meet the criteria in Accounting Principles Board Opinion No. 30, "Reporting the Results of OperationsReporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual and Infrequently Occurring Events and Transactions." SFAS No. 145 rescinds SFAS No. 64, "Extinguishments of Debt Made to Satisfy Sinking-Fund Requirements" and SFAS No. 4, "Reporting Gains and Losses from Extinguishment of Debt." This statement also amends SFAS No. 13, "Accounting for Leases" to require sale-leaseback accounting for certain lease modifications that have economic effects that are similar to sale-leaseback transactions. SFAS No. 145 also rescinds SFAS No. 44, "Accounting for Intangible Assets of Motor Carriers." This statement also makes various technical corrections to existing pronouncements which are not substantive in nature. The provisions of this statement related to the rescission of SFAS No. 4 shall be applied in fiscal years beginning after May 15, 2002, with early application encouraged. The provisions of this statement related to SFAS No. 13 shall be effective for transactions occurring after May 15, 2002, with early application encouraged. All other provisions of this statement shall be
7
effective for financial statements issued on or after May 15, 2002, with early application encouraged. The Company believes SFAS No. 145 will not have a material effect on the results of operations or financial position.
In June 2002, the FASB issued SFAS No. 146, "Accounting for the Costs Associated with Exit or Disposal Activities." SFAS No. 146 requires companies to recognize costs associated with exit or disposal activities when they are incurred rather than at the date of a commitment to an exit plan or disposal plan. This statement replaces Emerging Issues Task Force Issue No. 94-3, "Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring)." The provisions of this statement are to be applied prospectively to exit or disposal activities initiated after December 31, 2002, with early application encouraged.
3. Income Taxes
The income tax provision is determined by applying an estimated annual effective income tax rate to income before income taxes. The estimated annual effective income tax rate is based on the most recent annualized forecast of pretax income, permanent book/tax differences and tax credits.
4. Inventories
Inventories were comprised of the following:
| |
June 30, 2002 |
December 31, 2001 |
||||
|---|---|---|---|---|---|---|
| Raw materials | $ | 12,307,121 | $ | 9,783,562 | ||
| Work-in-process | 8,660,358 | 6,262,864 | ||||
| Finished goods | 10,742,851 | 7,483,259 | ||||
| Service parts | 2,822,169 | 3,239,277 | ||||
| Total inventories | $ | 34,532,499 | $ | 26,768,962 | ||
5. Goodwill and Other Intangible Assets
The Company adopted SFAS No. 142, "Goodwill and Other Intangible Assets," in the first quarter of fiscal 2002. SFAS No. 142 required that goodwill and intangible assets with indefinite useful lives not be amortized. Instead, in accordance with the provisions of SFAS No. 142, these assets will be tested for impairment annually, or on an interim basis when events or changes in circumstances warrant. Under the transitional provisions of SFAS No. 142, the Company tested goodwill and intangible assets with indefinite useful lives for impairment as of January 1, 2002 pursuant to the method prescribed by SFAS No. 142. Based on the first step of the impairment test, it is anticipated that an impairment loss for goodwill may be recorded in 2002; however, the Company is unable at this time to estimate the effect of this potential loss on earnings or financial position. Any impairment loss will be recorded as a cumulative effect of change in accounting principle on the consolidated statement of operations in accordance with the transitional provisions of SFAS No. 142.
Application of the non-amortization provisions of SFAS No. 142 will reduce amortization expense by approximately $165,000 in fiscal 2002. The following sets forth a reconciliation of net income (loss)
8
for the three and six months ended June 30, 2002 and 2001 adjusted for the non-amortization provisions of SFAS No. 142.
| |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
2002 |
2001 |
|||||||||
| Reported net income (loss) | $ | 608,584 | $ | (1,836,990 | ) | $ | 918,131 | $ | (1,572,551 | ) | |||
| Add back: goodwill amortization, net of tax | | 22,445 | | 22,445 | |||||||||
| Add back: trademarks and tradenames amortization, net of tax | | 1,918 | | 1,918 | |||||||||
| Adjusted net income (loss) | $ | 608,584 | $ | (1,812,627 | ) | $ | 918,131 | $ | (1,548,188 | ) | |||
The non-amortization provisions of SFAS No. 142 had no impact on basic and diluted earnings (loss) per share for the three and six months ended June 30, 2002 and 2001.
6. Other (Income) Expense
Other (income) expense was comprised of the following:
| |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
2002 |
2001 |
|||||||||
| Exchange (gains) losses on foreign currency transactions | $ | (1,529,493 | ) | $ | (104,112 | ) | $ | (1,305,926 | ) | $ | 110,735 | ||
| Depreciation (appreciation) of the fair value of derivative financial instruments | 138,175 | (141,209 | ) | 321,328 | (90,194 | ) | |||||||
| Total other (income) expense | $ | (1,391,318 | ) | $ | (245,321 | ) | $ | (984,598 | ) | $ | 20,541 | ||
7. Earnings (Loss) Per Share
Basic earnings (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares and, if applicable, common stock equivalents which would arise from the exercise of
9
stock options and conversion of preferred shares. The following table reconciles the numerators and denominators used to calculate basic and diluted earnings (loss) per share:
| |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
2002 |
2001 |
|||||||||||
| Income available to common shareholders: | |||||||||||||||
| Net income (loss) | $ | 608,584 | $ | (1,836,990 | ) | $ | 918,131 | $ | (1,572,551 | ) | |||||
| Preferred stock dividends | | (369,862 | ) | | | ||||||||||
| Preferred stock accretion | | 166,881 | | 166,881 | |||||||||||
| Net income (loss) available to common shareholdersbasic and diluted | $ | 608,584 | $ | (1,634,009 | ) | $ | 918,131 | $ | (1,739,432 | ) | |||||
| Weighted average shares outstanding: | |||||||||||||||
| Weighted average shares outstandingbasic | 56,180,338 | 38,753,416 | 56,105,338 | 38,752,960 | |||||||||||
| Effect of dilutive securities: | |||||||||||||||
| Stock options | 179,981 | | 311,742 | | |||||||||||
| Convertible preferred stock | | | | | |||||||||||
| Weighted average shares outstandingdiluted | 56,360,319 | 38,753,416 | 56,417,080 | 38,752,960 | |||||||||||
For the three and six months ended June 30, 2002, potential common shares from the stock options were anti-dilutive and excluded from the calculation of diluted earnings per share because the exercise price was greater than the average market price of the common shares. The number of shares excluded for stock options were 485,787 and 248,129 for the three and six months June 30, 2002, respectively.
For the three and six months ended June 30, 2001, potential common shares from the stock options and convertible preferred stock were anti-dilutive and excluded from the calculation of diluted earnings (loss) per share. The number of common shares excluded for stock options were 335,306 and 289,173 for the three and six months ended June 30, 2001, respectively. The number of common shares excluded for convertible preferred stock were 5,625,000 and 5,156,250, for the three and six months ended June 30, 2001, respectively.
For the three and six months ended June 30, 2001, net loss available to common shareholdersdiluted was equal to net loss available to common shareholdersbasic because of the anti-dilutive effect of the preferred stock accretion.
10
8. Comprehensive Income (Loss)
Comprehensive income (loss) for the three and six months ended June 30, 2002 and 2001 was as follows:
| |
Three Months Ended June 30, |
Six Months Ended June 30, |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
2002 |
2001 |
2002 |
2001 |
||||||||||
| Net income (loss) | $ | 608,584 | $ | (1,836,990 | ) | $ | 918,131 | $ | (1,572,551 | ) | ||||
| Other comprehensive income (loss): | ||||||||||||||
| Transition adjustment relating to the adoption of SFAS No. 133, net of taxes | | | ||||||||||||